the procedure is as follows : ( a ) blockade of those amino groups of antibodies whose integrity is essential to their antigen-binding activity with 2,3-dimethylmaleic anhydride , a reversible amino group-blocking reagent ;
C0282682
blockade
C1148575
antigen-binding